Acidity Level of Blood From Primary Molar's Pulp While Undergoing Pulpotomy or Pulpectomy Procedure
The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2013 by Hadassah Medical Organization.
Recruitment status was Recruiting
Information provided by (Responsible Party):
Moti Moskovitz, Hadassah Medical Organization
First received: December 3, 2011
Last updated: June 12, 2013
Last verified: June 2013
The aim of this study is to evaluate the level of acidity of blood samples that are been taken from pulp chambers of primary molars undergoing pulpotomy or pulpectomy procedures. Our hypothesis is that samples from teeth undergoing pulpectomy would be acidic while samples from teeth undergoing pulpotomy would bo neutral.
||Time Perspective: Prospective
||Characterization of Blood Drawn From the Pulp of Primary Molar Undergoing Pulpotomy or Pulpectomy.
Biospecimen Retention: None Retained
blood specimens which are undergoing Astrop test (acidity level .po2 pco2)
| Estimated Enrollment:
| Study Start Date:
| Estimated Primary Completion Date:
||December 2013 (Final data collection date for primary outcome measure)
theeth undergoing pulpotomy
teeth undergoing pulpectomy
The samples will be collected by 1 m"l syringe that is pre-washed with Heparin.than the samples will be analyzed in an Astrop machine of neonates.
|Ages Eligible for Study:
||3 Years to 13 Years
|Genders Eligible for Study:
|Accepts Healthy Volunteers:
healthy children undergoing dental treatment by residents in Hadassah hospital Jerusalem.
Ages between 3-13 years old.
- no systemic disease
- teeth that are undergoing pulpotomy or pulpectomy
- systemic disease
- pulp necrosis
- permanent teeth
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01486537
|Hadassah Medical Organization, Jerusalem, Israel
|Jerusalem, Israel, 91120 |
|Contact: Arik Tzukert, DMD 00 972 2 6776095 email@example.com |
|Contact: Hadas Lemberg, PhD 00 972 2 6777572 firstname.lastname@example.org |
|Principal Investigator: Moti Moskovitz, DMD, PhD |
Hadassah Medical Organization
||Moti Moskovitz, Dr.
||Hadassah Medical Organization
No publications provided
||Moti Moskovitz, dr, Hadassah Medical Organization
History of Changes
|Other Study ID Numbers:
|Study First Received:
||December 3, 2011
||June 12, 2013
||Israel: Ministry of Health
Keywords provided by Hadassah Medical Organization:
ClinicalTrials.gov processed this record on July 30, 2015
the age group 3-13 years